INTRODUCTION
Heterocyclic compounds are pharmacologically and medicinally very important because most of the drugs present in the market today are containing heterocyclic scaffolds. Benzoxazole derivatives exhibits anthelmintic 1 , antiulcer 2 , antitumor 3 , antimicrobial 4, 5 andanticancer 6 activities. Benzoxazole containing compounds are also acts as RSK2 inhibitor 7 and  1 -AR antagonist 8 .
Thiazole scaffold containing compounds are associated with anti-inflammatory 9 , activities. Pyrazole is one of the most important pharmacologically active heterocyclic compound. Pyrazole and its derivatives are associated with fungicidal 14 , anti-angiogenic 15 , antidiabetic 16 , antiparasitic 17 , antitubercular 18 , antimicrobial 19 and antioxidant 19 activities. The various pharmacological activities associated with benzoxazole, thiazole and pyrazole prompted us to synthesizesome novel thiazole anchored pyrazolyl benzoxazole derivatives.
EXPERIMENTAL
(1-(4-(4-Bromophenyl)thiazol-2-yl)-1H-pyrazol-4-yl)(2-hydroxyphenyl)methanone 3a-e 3-Formylchromone 1 (0.012 mol) was dissolved in 25 mL of ethanol with thiazolyl hydrazine 2 (0.012 mol). The reaction mixture heated under reflux for 40 min to get corresponding hydrazone. To the same reaction mixture 1.2 g KOH in 10 mL H 2 O was added and heating was continued for 4 hr. After completion of reaction the contents were cooled to room temperature and poured into crushed ice. The resulting solution was neutralized with conc. HCl. The solid obtained was separated by filtration and crystallized from ethanol to affordcompound 3. 
2-[(E)-{1-[4-(4-Bromophenyl)-1,3-thiazol-2-yl]-1H-pyrazol-4-yl}(hydroxyimino)methyl]phenol 4a-e
Compound 3 (0.055 mol) was dissolved in 20 mL of ethanol in 150 mL conical flask. To this 2-(1-(4-(4-Bromophenyl)thiazol-2-yl)-1H-pyrazol-4-yl) 
